Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Paul Silva who wrote (718)	2/11/1998 12:46:00 PM
From: READE SMITH	Read Replies (1) of 14101

WF-10 "supercharges" the immune system and presents a "completely new" (ie revolutionary) drug treatment for Aids, Cancer, Transplants, Burn Victims -- etc. That's what today's release really states. Dimethaid has been besieged with calls today asking for a layman's explanation of the study which "demonstrated that WF-10 is a potent inhibitor of antigen presentation by both dendritic cells and monocytes". With the results of this first independent study and follow-up to this weekend's presentation in Switzerland we have reached a whole new plateau for DMX. This is huge -- any Doctors on this thread care to comment?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next